Review
doi: 10.1016/s0002-9149(98)00250-1.
Regulatory concerns at various phases of drug development
Affiliations
- PMID: 9604895
- DOI: 10.1016/s0002-9149(98)00250-1
Item in Clipboard
Review
Regulatory concerns at various phases of drug development
Am J Cardiol.
.
No abstract available
Similar articles
-
What kinds of studies should be required to probe efficacy and safety of drugs in special populations?Am J Cardiol. 1998 Apr 23;81(8A):84F-87F. Am J Cardiol. 1998. PMID: 9604921 Review. No abstract available.
-
The challenge of regulating development and approval of drugs with pleiotropic action in cardiovascular disease.Am J Cardiol. 1998 Apr 23;81(8A):5F-9F. doi: 10.1016/s0002-9149(98)00249-5. Am J Cardiol. 1998. PMID: 9604896 Review. No abstract available.
-
Are the drug-regulatory agencies paper villains?Br Med J. 1980 Nov 15;281(6251):1333-5. doi: 10.1136/bmj.281.6251.1333. Br Med J. 1980. PMID: 7002251 Free PMC article. Clinical Trial. No abstract available.
-
Investigational new drug regs: icing or cake?Healthspan. 1988 Dec;5(11):25-6. Healthspan. 1988. PMID: 10291398 No abstract available.
-
AIDS and FDA drug-approval policy: an evolving controversy.J Health Soc Policy. 1990;2(2):39-46. doi: 10.1300/j045v02n02_03. J Health Soc Policy. 1990. PMID: 10111761
Cited by
-
Role of lipid-lowering pharmacotherapy in children.Paediatr Drugs. 2000 Jan-Feb;2(1):11-22. doi: 10.2165/00148581-200002010-00002. Paediatr Drugs. 2000. PMID: 10937455 Review.
-
Inhibition of acyl coenzyme A-cholesterol acyltransferase: a possible treatment of atherosclerosis?Curr Atheroscler Rep. 2002 Jan;4(1):65-70. doi: 10.1007/s11883-002-0064-9. Curr Atheroscler Rep. 2002. PMID: 11772425 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
